# Neddylation Targets and Stabilizes NLRP3 to Augment Inflammasome‐Mediated Colitis and Mood Disorder

## TL;DR

Neddylation stabilizes the NLRP3 protein, contributing to colitis and anxiety, and blocking it with MLN4924 may offer new treatment options.

## Contribution

Neddylation at K287 stabilizes NLRP3 by inhibiting its ubiquitination and degradation, revealing a novel regulatory mechanism.

## Key findings

- Neddylation at K287 prevents Trim31-mediated degradation of NLRP3.
- Myeloid UBA3 deficiency reduces colitis severity in mice.
- Neddylation inhibition with MLN4924 reduces anxiety-like behavior and NLRP3 activation.

## Abstract

The activation of NLRP3 inflammasome contributes to the development of numerous chronic inflammatory diseases, including ulcerative colitis and stress‐induced anxiety. Recent studies have revealed that NLRP3 K48‐linked ubiquitination by several E3 ligases, including Trim31, leads to degradation. Neddylation is a process highly similar to ubiquitination by covalently conjugating NEDD8 to lysines in specific substrate proteins. Neddylation of substrate proteins alters their subcellular localization, stability, and activity. The role of neddylation in the NLRP3 inflammasome remains elusive. Here, we report that neddylation promotes the activation of the NLRP3 inflammasome in macrophages. Myeloid deficiency of UBA3, the catalytic subunit of the NEDD8‐activating enzyme (NAE), renders mice resistant to dextran sodium sulfate‐induced colitis. Inducible Uba3 deletion in microglia mitigates psychological stress‐induced anxiety‐like behavior. Neddylation blockade led to a reduced protein level of NLRP3 without affecting its mRNA level. Further exploration revealed that NLRP3 undergoes neddylation at K287 with Ube2M as the E2 and Smurf2 as an E3, respectively. NLRP3 neddylation hinders its interaction with Trim31 and thereby inhibits its K48‐linked ubiquitination and subsequent degradation. MLN4924, a potent compound NAE inhibitor in phase 1/2/3 clinical trials for cancers, alleviates psychological stress‐induced NLRP3 inflammasome activation, microglia inflammatory activation, and anxiety‐like behavior, suggesting novel clinical activity of MLN4924.

NLRP3 inflammasome contributes to colitis and mood disorder. This study demonstrates that neddylation targets NLRP3 at K287, which hinders its interaction with K48‐linked ubiquitination E3 Trim31 and thereby stabilizes it. Neddylation blockade in myeloid cells and microglia mitigates DSS‐induced colitis and psychological stress‐induced anxiety‐like behavior, respectively. Neddylation inhibitor MLN4924 also alleviates psychological stress‐induced mood disorder, suggesting potential clinical application.